Common Anti-Inflammatory drug may protect hearts during risky surgery
NCT ID NCT05726019
Summary
This study tested whether giving the anti-inflammatory drug colchicine to patients before and after heart bypass surgery could reduce serious complications. It involved 100 patients who had recently suffered a heart attack and needed bypass surgery. Patients received either colchicine or standard care for 30 days around their surgery to see if it prevented problems like irregular heartbeats, inflammation, or further heart damage.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY BYPASS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Heart Institute - University of São Paulo
São Paulo, São Paulo, 05403000, Brazil
Conditions
Explore the condition pages connected to this study.